Suvemcitug placebo injection, trifluridine/tipiracil tablets Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd.1

Indications

Refractory Metastatic Colorectal Cancer1
Cancer1

Other1 trial

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.